Stay Continue Operations

Zentiva is a pharmaceutical company based in Prague, Czech Republic. The company is developing, manufacturing and marketing a wide range of generic and OTC products. Zentiva employs more than 4 700 people across Europe and has three manufacturing sites, in Prague, Bucharest and Ankleshwar.

Stay Continue Operations
Revenue(RF), mln.USD
89
Assets(RF), mln.USD
47
Capital(RF), mln.USD
17
Staff(RF), 2021
173
Taxes(RF), mln.USD
3
Glob.Revenue, mln.USD
50261
The Company Statement
March 28, 2025

Received revenues in Russia in 2022-2024. Zentiva sells operations in Russia and CIS markets, no details disclosed officially so far. Revenue increased in 2024 vs 2023 by more than +30%.

Open the Statement
Statements Archive
April 07, 2020Zentiva extends commercial footprint by completing acquisition of CEE business from Alvogen
October 25, 2019Zentiva to further expand its geographical footprint and complement its portfolio in Generics and OTC
Demand to Leave Russia:Petition text has been copied to the clipboard.
Share the Company Status:
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner